0.8590 USD
-0.0037
0.43%
At close Jun 13, 4:00 PM EDT
1 day
-0.43%
5 days
-12.25%
1 month
-14.95%
3 months
-59.48%
6 months
-72.56%
Year to date
-74.05%
1 year
-83.09%
5 years
-99.85%
10 years
-99.96%
 

About: cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Employees: 42

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

41% more funds holding

Funds holding: 17 [Q4 2024] → 24 (+7) [Q1 2025]

22% more capital invested

Capital invested by funds: $69.3K [Q4 2024] → $84.4K (+$15.2K) [Q1 2025]

2.61% more ownership

Funds ownership: 3.34% [Q4 2024] → 5.95% (+2.61%) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$3
249%
upside
Avg. target
$3
249%
upside
High target
$3
249%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Maxim Group
Tom McGovern
249%upside
$3
Buy
Maintained
22 May 2025

Financial journalist opinion

Neutral
Newsfile Corp
3 weeks ago
Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia
Charlotte, North Carolina--(Newsfile Corp. - May 21, 2025) - Herbal Oasis ("Oasis"), the hemp-derived THC-infused social seltzer redefining how people connect, unwind, and celebrate life, is proud to announce a new distribution partnership with Beverage South, a leading distributor serving much of the state of Georgia. Starting this month, Oasis will be available on shelves across Georgia as the brand continues its rapid expansion across the Southeast.
Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia
Neutral
Seeking Alpha
1 month ago
cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q2 2025 Earnings Conference Call May 15, 2025 4:20 PM ET Company Participants Brad Whitford – Chief Accounting Officer Ronan Kennedy – Chief Executive Officer and Chief Financial Officer Conference Call Participants Tom McGovern – Maxim Group Adam Waldo – Lismore Partners Operator Good afternoon. Welcome to the cbdMD, Inc. Conference Call to discuss results for their Second Quarter Fiscal 2025 period ending March 25, 2025.
cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript
Neutral
Newsfile Corp
1 month ago
cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter
Successfully Completes Capital Structure Reset with Series A Preferred Conversion Charlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.
cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter
Neutral
Newsfile Corp
1 month ago
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Charlotte, North Carolina--(Newsfile Corp. - May 9, 2025) - cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, May 15, 2025, to discuss the company's March 31, 2025 second quarter of fiscal year 2025 financial results and business progress.
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Neutral
Newsfile Corp
1 month ago
Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
Charlotte, North Carolina--(Newsfile Corp. - May 7, 2025) - Herbal Oasis ("Oasis"), the hemp derived THC-infused social seltzer brand redefining how people connect, unwind, and celebrate life, is now proud to be distributed by Carolina Premium Beverage, serving Charlotte NC and surrounding counties. Starting in May, consumers will be able to find Oasis on shelves across North Carolina.
Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
Neutral
Newsfile Corp
1 month ago
Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards
Charlotte, North Carolina--(Newsfile Corp. - April 24, 2025) - Herbal Oasis, a rising star in the alternative hemp beverage space, has earned national acclaim with a Gold Medal for Mango Bliss, Silver Medal for both Lemon Lift and Tropical Twist and a Bronze Medal for Berry Fusion at the 2025 High Spirits Awards, a leading showcase of excellence in cannabinoid-infused drinks hosted by the L.A. Spirits Awards in California.
Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards
Neutral
Newsfile Corp
1 month ago
cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion
Charlotte, North Carolina--(Newsfile Corp. - April 21, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD PRA) (the "Company") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, announced today that the automatic conversion (the "Conversion") of shares of its 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock"), into the Company's Common Stock, $0.001 par value per share (the "Common Stock") will be effective at 4:01 p.m. Eastern Time on May 6, 2025 (the "Mandatory Exchange Date").
cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion
Neutral
Newsfile Corp
2 months ago
cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting
Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Company's Common Stock. The Company intends to set a mandatory exchange date for the Preferred Stock in the near future (the "Mandatory Exchange Date").
cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting
Neutral
Newsfile Corp
2 months ago
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval
FSA Publishes Safety Assessment for cbdMD's Proprietary CBD Ingredient Charlotte, North Carolina--(Newsfile Corp. - April 7, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leader in premium hemp-derived cannabidiol (CBD) products, proudly announces that its Novel Food dossier (RP793) has advanced to the last phase of regulatory assessment with the UK Food Standards Agency (FSA), nearing final approval. This milestone not only underscores cbdMD's commitment to safety, quality, and scientific excellence but also reflects its position as a trusted brand in the growing CBD market, offering consumers confidence in purchasing compliant and rigorously tested products.
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval
Neutral
Seeking Alpha
3 months ago
cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript
cbdMD, Inc. (NYSE:YCBD ) Q1 2025 Earnings Conference Call February 13, 2025 4:20 PM ET Company Participants Brad Whitford - Chief Accounting Officer Ronan Kennedy - Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Adam Waldo - Lismore Partners, LLC Thomas McGovern - Maxim Group Operator Good afternoon. Welcome to the cbdMD, Inc.'s December 31, 2024, First Fiscal Quarter of 2025 Earnings Call and Update.
cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript
Charts implemented using Lightweight Charts™